- McLaughlin, P., Grill-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. and Dallaire, B.K. (1998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program", J. Clin. Oncol. 16(8), 2825-2833.
- D'Arena, G., Pellegrin, M., Cascavilla, N., Dell'Olio, M., Di Renzo, N. and Carotenuto, M. (2000) "Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders", Am.J. Hematol. 64, 275-281.
- Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V. and Engert, A. (1999) "Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD 20 monoclonal antibody (Rituximab, IDEC-C2B8)", Blood 94(7), 2217-2224.
- Ladetto, M., Bergui, L., Ricca, I., Campana, S., Pileri, A. and Tarella, C. (2000) "Rituximab anti-CD 20 monoclonal antibody induces marked but transient reduction of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients", Med. Oncol. 17, 203-210.
- Cheson, B.D. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990-4997.
- Fruehauf, S., Topaly, J., Wilmes, A. and Ho, A.D. (2000) "Durchflusszytometrische Diagnostik maligner hämatologischer Erkrankungen", In: Zeller, W.J. and zur Hausen, H., eds, Onkologie (Ecomed, Landsberg/Lech), Chapter II-4, pp 1-32.
- Ginaldi, L., Martinis, M., Matutes, E., Farahat, N., Morilla, R. and Catovsky, D. (1998) "Levels of expression of CD 19 and CD 20 in chronic B-cell leukaemias", J. Clin. Pathol. 51(5), 364-369.
- Herold, M., Schulze, A., Härtwig, K. and Anger, G. (2000) "Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab", Ann. Hematol. 79, 332-335.
- Drapkin, R. (2000) "Pentostatin and rituximab in the treatment of patients with B-cell malignancies", Oncology 14(6), 25-29.
Level of CD 20-expression and Efficacy of Rituximab Treatment in Patients with Resistant or Relapsing B-cell Prolymphocytic Leukemia and B-cell Chronic Lymphocytic Leukemia
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.